Jaguar Health Inc (JAGX) is higher by Monday morning, with the stock adding 4.35% in pre-market trading to 1.44. JAGX's short-term technical score of 34 indicates that the stock has traded less bullishly over the last month than 66% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 64% of stocks. Jaguar Health Inc has fallen 35.21% over the past month, closing at $2.13 on November 1. During this period of time, the stock fell as low as $1.37 and as high as $2.25. JAGX has an average analyst recommendation of Strong Buy. The company has an average price target of $5.88.
JAGX has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on JAGX!